N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells

Leukemia & Lymphoma
L N ChanT S Chan

Abstract

We demonstrate that N-(4-hydroxyphenyl)-all-trans-retinamide (4-HPR), a synthetic retinoic acid (RA) derivative, is a potent and selective inducer of apoptosis in malignant T lymphoid cells, but has little effect on normal lymphoid cells of the thymus or spleen. 4-HPR and its stereoisomer, 9-cis-4-HPR, are 50 to > 150 times more potent than 7 other retinoids in killing CEM-C7 human T lymphoblastoid leukemia cells and P1798-C7 murine T lymphoma cells. 4-HPR's apoptotic action requires the intact molecule bearing both the retinoid moiety and the hydroxyphenol ring; 4-HPR remains unmetabolized after uptake into CEM-C7 and P1798-C7 cells for up to 24 hours. We also show that glucocorticoid (GC)-resistant variants are equally susceptible to 4-HPR as are GC-sensitive cells. Thus, 4-HPR may be potentially important as a new chemotherapeutic drug for use as alternative to, or in combination with, conventional drugs for treating lymphoid malignancies.

References

Feb 1, 1980·Molecular and Cellular Endocrinology·E A Thompson
Jun 1, 1981·Molecular and Cellular Biology·J M Harmon, E B Thompson
Nov 1, 1994·International Journal of Cancer. Journal International Du Cancer·A Di VinciW Giaretti
Aug 17, 1994·Journal of the National Cancer Institute·A MariottiG Della Valle
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F FormelliU Veronesi

❮ Previous
Next ❯

Citations

Jan 5, 2002·Hematology/oncology Clinics of North America·C P Reynolds, R S Lemons
Aug 17, 1999·Cancer Treatment Reviews·E Ulukaya, E J Wood
Sep 2, 1998·International Journal of Cancer. Journal International Du Cancer·A M DiPietrantonioJ M Wu
Apr 27, 2004·Molecular Carcinogenesis·Mohamed KabboutNadine Darwiche
Feb 14, 2009·Clinical Genitourinary Cancer·Eric CheungDavid R Gandara
Jul 20, 2006·Apoptosis : an International Journal on Programmed Cell Death·N HailR Lotan
Apr 3, 1999·International Journal of Cancer. Journal International Du Cancer·P G MontaldoM Ponzoni
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Barry J MaurerC Patrick Reynolds

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis